Florent Petitprez

Active 2016–2024

39
Papers
18,033
Citations
32
h-index
38
i10-index

Citations

Citations per year for Florent Petitprez1974: 2 citations2009: 1 citations2011: 1 citations2013: 1 citations2016: 1 citations2017: 18 citations2018: 51 citations2019: 197 citations2020: 734 citations2021: 1,256 citations2022: 1,302 citations2023: 1,143 citations2024: 1,846 citations2025: 1,066 citations2026: 35 citations1975–2008: no citations, so these years are not shown2010: no citations, so this year is not shown2012: no citations, so this year is not shown2014–2015: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,296 citing papers, 28.5% of this breakdownUnited States: 1,620 citing papers, 20.1% of this breakdownFrance: 451 citing papers, 5.6% of this breakdownUnited Kingdom: 371 citing papers, 4.6% of this breakdownGermany: 349 citing papers, 4.3% of this breakdownItaly: 291 citing papers, 3.6% of this breakdownNetherlands: 196 citing papers, 2.4% of this breakdownSpain: 191 citing papers, 2.4% of this breakdownJapan: 183 citing papers, 2.3% of this breakdownCanada: 176 citing papers, 2.2% of this breakdownSwitzerland: 172 citing papers, 2.1% of this breakdownAustralia: 171 citing papers, 2.1% of this breakdown
0%28.5%Other 19.8%

Fields

  • Medicine54.9%
  • Biochemistry, Genetics and Molecular Biology23%
  • Immunology and Microbiology18.7%
  • Engineering1.2%
  • Computer Science0.6%
  • Neuroscience0.5%
  • Other1.1%

Topics

  • Cancer Immunotherapy and Biomarkers14.9%
  • Immunotherapy and Immune Responses6.4%
  • Ferroptosis and cancer prognosis6.3%
  • Immune cells in cancer5.5%
  • Immune Cell Function and Interaction4.6%
  • Single-cell and spatial transcriptomics4%
  • Other58.3%

Coauthors

All papers

Open in search
  1. B cells and tertiary lymphoid structures promote immunotherapy response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christine N. Spencer, Elizabeth M. Burton, Lauren E. Haydu, Alexander J. Lazar, Roberta Zapassodi, Courtney W. Hudgens, Deborah A. Ledesma, SuFey Ong, Michael Bailey, Sarah Warren, Disha Rao, Oscar Krijgsman, Elisa A. Rozeman, Daniel S. Peeper, Christian U. Blank, Ton N. Schumacher, Lisa H. Butterfield, Monika A. Zelazowska, Kevin M. McBride, Raghu Kalluri, James P. Allison, Florent Petitprez, Wolf H. Fridman, Catherine Sautès‐Fridman, Nir Hacohen, Katayoun Rezvani, Padmanee Sharma, Michael T. Tetzlaff, Linghua Wang, Jennifer A. Wargo - Nature 2020 cited by 2,745

  2. Tertiary lymphoid structures in the era of cancer immunotherapy

    Authors: , , , - Nature reviews. Cancer 2019 cited by 1,784

  3. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

    Authors: , , , , , , , , , , - Genome biology 2016 cited by 3,993

  4. B cells are associated with survival and immunotherapy response in sarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,970

  5. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Immunity 2022 cited by 771

  6. B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

    Authors: , , , , , - Nature Reviews Clinical Oncology 2022 cited by 633

  7. The clinical role of the TME in solid cancer

    Authors: , , , , , , , , , , - British Journal of Cancer 2018 cited by 758

  8. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma

    Authors: , , , , , , , , , , , , - Journal of Hepatology 2018 cited by 468

  9. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology

    Authors: , , , , , , , - Bioinformatics, Bioinform. 2019 cited by 1,011

  10. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies

    Authors: , , , , - Frontiers in Immunology 2020 cited by 641

  11. Erratum to: Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression

    Authors: , , , , , , , , , , - Genome biology 2016 cited by 298

  12. Context-dependent roles of complement in cancer

    Authors: , , , , - Nature reviews. Cancer 2019 cited by 383

  13. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xavier Cathelineau, Catherine Sautès‐Fridman, Wolf H. Fridman - Cancer Immunology Research 2019 cited by 274

  14. B cells and cancer: To B or not to B?

    Authors: , , , , , , - The Journal of Experimental Medicine 2020 cited by 193

  15. Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 106

  16. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 414

  17. The murine Microenvironment Cell Population counter method to estimate abundance of tissue-infiltrating immune and stromal cell populations in murine samples using gene expression

    Authors: , , , , , , , , , , , , - Genome Medicine 2020 cited by 154

  18. Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal for ImmunoTherapy of Cancer 2020 cited by 106

  19. Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy

    Authors: , , , , , , , , , , , , , , , , , , - Blood 2017 cited by 183

  20. SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils

    Authors: , , , , , , , , , , , , , , , , - Lung Cancer 2022 cited by 45

  21. Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer

    Authors: , , , , , , , - Seminars in Immunology 2020 cited by 79

  22. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies

    Authors: , , , , , , , , , , , , , , , - Kidney International 2017 cited by 107

  23. Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer

    Authors: , , , , , , , , , , - Cancer Immunology Immunotherapy 2018 cited by 81

  24. Results from a nationwide retrospective cohort measure the impact of C3 and soluble C5b-9 levels on kidney outcomes in C3 glomerulopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2022 cited by 41